Disease Progression Events in Trials of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis

被引：0

作者：

Nathan, S. D. ^{[1
]}

Costabel, U. ^{[2
]}

Lancaster, L. H. ^{[3
]}

Corte, T. J. ^{[4
,5
]}

Nunes, H. ^{[6
]}

Schinzel, B. ^{[7
]}

Quaresma, M. ^{[7
]}

Wells, A. U. ^{[8
,9
]}

机构：

[1] Inova Fairfax Hosp, Falls Church, VA USA

[2] Univ Duisburg Essen, Ruhrlandklin, Univ Hosp, Essen, Germany

[3] Vanderbilt Univ, Med Ctr, Nashville, TN USA

[4] Royal Prince Alfred Hosp, Camperdown, NSW, Australia

[5] Univ Sydney, Sydney, NSW, Australia

[6] Hop Avicenne, APHP, Dept Pulmonol, Bobigny, France

[7] Boehringer Ingelheim Int GmbH, Ingelheim, Germany

[8] Royal Brompton & Harefield NHS Fdn Trust, Natl Inst Hlth Res Resp Biomed Res Unit, London, England

[9] Imperial Coll, Natl Heart & Lung Inst, London, England

来源：

关键词：

D O I：

暂无

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

A4548

引用

页数：2